Terns Pharmaceuticals and Summit Therapeutics are in the spotlight following positive updates on key candidates.
Vous n'êtes pas connecté
Novavax and Alnylam are in the spotlight following drug approval and regulatory updates, respectively.
Terns Pharmaceuticals and Summit Therapeutics are in the spotlight following positive updates on key candidates.
Terns Pharmaceuticals and Summit Therapeutics are in the spotlight following positive updates on key candidates.
Novavax (NVAX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Though Novavax is behind in the COVID-19 vaccine race, a blockbuster deal with Sanofi and a differentiated product means the stock offers the best...
Providers of vaccines against African swine fever (ASF) from four countries are seeking the Food and Drug Administration’s (FDA) approval, according...
Providers of vaccines against African swine fever (ASF) from four countries are seeking the Food and Drug Administration’s (FDA) approval, according...
Drug company Indies Pharma Jamaica Limited is looking to double next year’s revenues, following approval of its abbreviated new drug application,...
The Food and Drug Administration (FDA), as many are aware, is the leading entity for the regulation and safety testing for foods and pharmaceuticals...
Business News LIVE Updates Today: Get real-time updates on the biggest news from the world of business, stock market and more.
TRIB announces updates on its European patented process. The company aims to use this process to improve the functionality of its glucose biosensor in...